None
EN
‘Suggestions not accepted’: Bill to overhaul drugs law faces opposition from pharma, medical device sector
['Anonna Dutt', 'Anonna Dutt Is A Principal Correspondent Who Writes Primarily On Health At The Indian Express. She Reports On Myriad Topics Ranging The Growing Burden Of Non-Communicable Diseases Such As Diabetes', 'Hypertension To The Problems With Pervasive Infectious Conditions. She Reported On The Government S Management Of The Pandemic', 'Closely Followed The Vaccination Programme.', 'Her Stories Have Resulted In The City Government Investing In High-End Tests For The Poor', 'Acknowledging Errors In Their Official Reports.', 'Dutt Also Takes A Keen Interest In The Country S Space Programme', 'Has Written On Key Missions Like Chandrayaan', 'Aditya', 'Gaganyaan.']
The Indian Express
A Bill to overhaul the Drugs and Cosmetics Act, 1940, currently being circulated to stakeholder ministries, is facing fierce opposition from the country’s nascent medical device sector.
Multiple pharmaceutical and medical device associations complained that no stakeholder consultation was undertaken during the drafting process.
The Association of Indian Medical Device Industry has written a letter to Union Health Minister J P Nadda flagging the issues with the Bill.
Explained Criminalising technical lapses The industry body said the new Bill criminalises administrative and technical lapses, which is internationally unprecedented.
It has been revived without any of the changes that the industry had requested,” said a medical device industry expert, on condition of anonymity.